Angiogenesis Inhibitors: all 4,430 studies that test it

Page 19 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.

• Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT00397488Phase 2Results posted
• AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant AscitesCompletedNCT00396591Phase 2Results posted
• Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerCompletedNCT00394433Phase 2Results posted
• ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast CancerCompletedNCT00394082Phase 2Results posted
• Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast CancerCompletedNCT00393939Phase 3Results posted
• Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor PatientsCompletedNCT00393861Phase 2Results posted
• Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial CarcinomaTerminatedNCT00393796Phase 2Results posted
• Bevacizumab and Irinotecan to Treat Brain TumorsTerminatedNCT00393094Phase 2Results posted
• Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal CancerCompletedNCT00393068Phase 2Results posted
• Treatment of Head & Neck Cancer With Chemotherapy and RadiationCompletedNCT00392704Phase 2Results posted
• Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00392665Phase 2Results posted
• Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell LymphomaCompletedNCT00392496Phase 2Results posted
• Sunitinib in Treating Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT00392444Phase 2Results posted
• Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast CancerCompletedNCT00392392Phase 2Results posted
• Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNCT00390416Phase 2Results posted
• Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaCompletedNCT00390234Phase 2Results posted
• Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By SurgeryCompletedNCT00389974Phase 2Results posted
• Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00388037Phase 2Results posted
• Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant MelanomaCompletedNCT00387751Phase 2Results posted
• Sunitinib in Treating Patients With Idiopathic MyelofibrosisTerminatedNCT00387426Phase 2Results posted
• Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00387335Phase 2Results posted
• Lucentis (Ranibizumab) for Eales' DiseaseCompletedNCT00384449Phase 2/3Results posted
• Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade GliomaCompletedNCT00381797Phase 2Results posted
• Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryCompletedNCT00381641Phase 2Results posted
• An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVOCompletedNCT00379795Not applicableResults posted
• The Effects of Thalidomide on Symptom ClustersCompletedNCT00379353Phase 2Results posted
• Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney CancerCompletedNCT00378703Phase 2Results posted
• Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerTerminatedNCT00378573Phase 2Results posted
• Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple MyelomaCompletedNCT00378209Phase 2Results posted
• Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple MyelomaActive, not recruitingNCT00378105Phase 1/2Results posted
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell CancerCompletedNCT00375674Phase 3Results posted
• A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast CancerCompletedNCT00373256Phase 3Results posted
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And CapecitabineTerminatedNCT00373113Phase 3Results posted
• Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain MetastasesCompletedNCT00372775Phase 2Results posted
• Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal TumorsTerminatedNCT00372567Phase 3Results posted
• VEGF Trap in Treating Patients With Metastatic Breast CancerCompletedNCT00369655Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to TemozolomideCompletedNCT00369590Phase 2Results posted
• Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical CancerCompletedNCT00369122Phase 2Results posted
• S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00368992Phase 2Results posted
• Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast CancerCompletedNCT00368875Phase 1/2Results posted
• Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung CancerCompletedNCT00367601Phase 2Results posted
• Gemcitabine, Bevacizumab and Erlotinib in Pancreatic CancerCompletedNCT00366457Phase 2Results posted
• Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic ChemotherapyCompletedNCT00365547Phase 2Results posted
• Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast CancerCompletedNCT00365417Phase 2Results posted
• Bevacizumab and Erlotinib in Treating Patients With Advanced Liver CancerCompletedNCT00365391Phase 2Results posted
• Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast CancerCompletedNCT00365365Phase 2Results posted
• Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With GemcitabineCompletedNCT00365144Phase 2Results posted
• Ranibizumab in Hemorrhagic Choroidal Neovascularization TrialCompletedNCT00363168Phase 1Results posted
• Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder CancerCompletedNCT00361231Phase 2Results posted
• Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic SyndromeCompletedNCT00360672Phase 2Results posted
• Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary SiteCompletedNCT00360360Phase 2Results posted
• Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00357760Phase 2Results posted
• Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive CancerCompletedNCT00357500Phase 2Results posted
• Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary TumorsCompletedNCT00356889Phase 2Results posted
• Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00356122Phase 2Results posted
• Bevacizumab and Radiation Therapy for SarcomasCompletedNCT00356031Phase 2Results posted
• Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer PatientsCompletedNCT00354978Phase 2Results posted
• Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00354679Phase 2Results posted
• Lenalidomide for Patients With Myelofibrosis (MF)CompletedNCT00352794Phase 2Results posted
• Lenalidomide in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00352365Phase 2Results posted
• Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesCompletedNCT00352001Phase 1/2Results posted
• Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung CancerTerminatedNCT00351039Phase 1/2Results posted
• Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate CancerCompletedNCT00348595Phase 1/2Results posted
• A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLCCompletedNCT00343291Phase 2Results posted
• Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn CancersCompletedNCT00343044Phase 2Results posted
• Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney CancerCompletedNCT00338884Phase 2Results posted
• Bevacizumab in Treating Patients With Recurrent or Progressive GliomaCompletedNCT00337207Phase 2Results posted
• A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)CompletedNCT00336323Phase 2Results posted
• Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00335829Phase 2Results posted
• Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryActive, not recruitingNCT00334815Phase 2Results posted
• A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast CancerCompletedNCT00333775Phase 3Results posted
• SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular DegenerationCompletedNCT00331864Phase 3Results posted
• Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to FollowTerminatedNCT00330564Phase 2Results posted
• Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant AscitesCompletedNCT00327444Phase 2/3Results posted
• Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian CancerCompletedNCT00327171Phase 2Results posted
• Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By SurgeryCompletedNCT00326898Phase 3Results posted
• Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal TumorTerminatedNCT00324987Phase 3Results posted
• Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00324870Phase 1/2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryCompletedNCT00324805Phase 3Results posted
• Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung CancerCompletedNCT00323869Phase 2Results posted
• Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal CarcinomaCompletedNCT00323739Phase 2Results posted
• Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By SurgeryCompletedNCT00321828Phase 2Results posted
• Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal CancerCompletedNCT00321685Phase 2Results posted
• Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical ProstatectomyCompletedNCT00321646Phase 2Results posted
• Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without BevacizumabTerminatedNCT00321100Phase 2Results posted
• Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)CompletedNCT00320788Phase 2Results posted
• A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)CompletedNCT00318136Phase 2Results posted
• A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)CompletedNCT00312728Phase 2Results posted
• Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix CancerCompletedNCT00310076Phase 2Results posted
• 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal CancerCompletedNCT00308516Phase 2Results posted
• Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal CancerCompletedNCT00307736Phase 1/2Results posted
• Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)CompletedNCT00307294Phase 2Results posted
• Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By SurgeryCompletedNCT00305877Phase 2Results posted
• Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal CancerTerminatedNCT00303628Phase 3Results posted
• Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00301964Phase 2Results posted
• Study of SU11248 in Men With Advanced Prostate CancerCompletedNCT00299741Phase 2Results posted
• TEACO: Taxotere, Eloxatin, Avastin in Cancer of the OvaryCompletedNCT00296816Phase 2Results posted
• Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant MesotheliomaCompletedNCT00295503Phase 2Results posted
• Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell LymphomaCompletedNCT00294632Phase 1/2Results posted
• Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast CancerCompletedNCT00291577Phase 1Results posted

← Angiogenesis Inhibitors overview